Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today
The drugmaker confirmed there's a strong market for two of its treatments.Shares of drugmaker Catalyst Pharmaceuticals (CPRX 4.67%) are up a little more than 8% as of midday on Thursday, down slightly from an intraday peak gain of nearly 13%. The company's fourth-quarter results posted after Wednesday's close were markedly better than expected.Encouraging numbers from CatalystCatalyst Pharmaceuticals' specialty is treating rare diseases, which inherently leaves it off of most investors' radars.Nevertheless, ...